seems the executive teams for Biogen and Zosano have been meeting a lot as of late.. backfilling that empty pipeline. apparently a quarter of funds earmarked for the 1 billion stock buyback will actually go towards acquiring this migraine therapy in a cash and stock deal. Being scooped up now. Deal to be announced in next 2 weeks. Nothing novel, but the micro-needle stamp costs 10 a pop to make, has already gotten FDA greenlight (new commish and investor on the board went to prep school together) and will be sold for at least a couple hundred per dose. Low hanging fruit, but easy profit. $$ Marketing to start Jan next year. You’re welcome
No, just typical lies like most everything on this site. Most likely just some one trying to pump and dump a stock.
